Abstract | OBJECTIVE: METHODS: In this retrospective cohort study involving 866 participants diagnosed with COVID-19, patients were grouped by severity. Generalized additive models were established to explore the time-course association of representative parameters of coagulation, inflammation and immunity. Segmented regression was performed to examine the influence of corticosteroids and heparin upon CD8+ T cell and D-dimer, respectively. RESULTS: There were 541 moderate, 169 severe and 156 critically ill patients involved in the study. Synchronous changes of levels of NLR, D-dimer and CD8+ T cell in critically ill patients were observed. Administration of methylprednisolone before 14 DFS compared with those after 14 DFS (β = 0.154%, 95% CI=(0, 0.302), p=.048) or a dose lower than 40 mg per day compared with those equals to 40 mg per day (β = 0.163%, 95% CI=(0.027, 0.295), p=.020) significantly increased the rising rate of CD8+ T cell in 14-56 DFS. CONCLUSIONS: The parameters of coagulation, inflammation and immunity were longitudinally correlated, and an early low-dose corticosteroid treatment accelerated the regaining of CD8+ T cell to help battle against SARS-Cov-2 in critical cases of COVID-19.
|
Authors | Fangzhou Ye, Jing Liu, Liangkai Chen, Bin Zhu, Li Yu, Boyun Liang, Ling Xu, Sumeng Li, Sihong Lu, Lei Fan, Dongliang Yang, Xin Zheng |
Journal | Annals of medicine
(Ann Med)
Vol. 53
Issue 1
Pg. 181-188
(12 2021)
ISSN: 1365-2060 [Electronic] England |
PMID | 33183091
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Fibrin Fibrinogen Degradation Products
- Glucocorticoids
- fibrin fragment D
- Heparin
- Methylprednisolone
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Blood Coagulation
(drug effects, immunology)
- CD8-Positive T-Lymphocytes
(drug effects, immunology)
- COVID-19
(blood, diagnosis, immunology)
- Dose-Response Relationship, Drug
- Female
- Fibrin Fibrinogen Degradation Products
(analysis, immunology)
- Glucocorticoids
(administration & dosage)
- Heparin
(administration & dosage)
- Humans
- Inflammation
(blood, diagnosis, drug therapy, immunology)
- Linear Models
- Longitudinal Studies
- Lymphocyte Count
- Male
- Methylprednisolone
(administration & dosage)
- Middle Aged
- Models, Biological
- Retrospective Studies
- SARS-CoV-2
(immunology, isolation & purification)
- Severity of Illness Index
- Time Factors
- Time-to-Treatment
- Young Adult
- COVID-19 Drug Treatment
|